The Community Focus Channel on VJHemOnc is an independent medical education platform, supported with funding from Johnson & Johnson (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2025 | Predictors of ICU survival in patients with hematological malignancies
Shivani Modi, MD, Jefferson Einstein Montgomery Hospital, Philadelphia, PA, shares the findings of a study investigating predictive factors for ICU survival and outcomes in patients with hematological malignancies. Dr Modi highlights that post-chemo monitoring surveillance, such as regular follow-up with a nurse navigator, was the only predictive factor identified, with patients receiving such care having a better outcome. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
